335 filings
Page 3 of 17
8-K
adaqtfz4nhtsdn
28 Oct 20
GenMark Diagnostics Reports Third Quarter 2020 Results
4:07pm
8-K
txbg dtt5t
8 Oct 20
GenMark Diagnostics Provides Preliminary Financial Results for Third Quarter 2020
4:04pm
8-K
ukxl3tp g2myedtkcb35
23 Sep 20
Departure of Directors or Certain Officers
4:30pm
8-K
czc6jzn8txhk7pku91
11 Sep 20
Departure of Directors or Certain Officers
4:33pm
8-K
954nr
4 Aug 20
GenMark Diagnostics Reports Second Quarter 2020 Results
4:15pm
8-K
16kb2cz4yz 35cci
8 Jul 20
Entry into a Material Definitive Agreement
4:12pm
8-K
13gi3odvxnoy
7 Jul 20
GenMark Diagnostics Provides Preliminary Financial and Operational Results for Second Quarter 2020 Revenue Expected to Represent Approximately 118% Year-Over-Year Growth
4:09pm
8-K
j1z6v4ye3h 4l0ze
2 Jun 20
Amended and Restated Executive Employment Agreement
4:22pm
SD
uvgohsni1a2qzfjr2
1 Jun 20
Conflict minerals disclosure
4:23pm
S-8
yc92 n8yng
29 May 20
Registration of securities for employees
5:14pm
8-K
u4qvsv5fvdwvwqahi
11 May 20
Other Events
4:11pm
8-K
l54 dv4pf7bt
7 May 20
GenMark Commences Public Offering of Common Stock
4:59pm
424B5
3q75c1
7 May 20
Prospectus supplement for primary offering
4:55pm
424B5
p4xr1aw
6 May 20
Prospectus supplement for primary offering
4:07pm
DEFA14A
2nbckv5wgxzq44xe53v
4 May 20
Additional proxy soliciting materials
4:15pm
8-K
oz2p4uxbp
4 May 20
GenMark Diagnostics Reports First Quarter 2020 Results
4:10pm
DEFA14A
78luod 5747
15 Apr 20
Additional proxy soliciting materials
4:38pm